文献速递肿瘤 PET/CT

基线[18F]-FDG PET/CT总代谢肿瘤体积与脾代谢为切除乳腺癌独立复发预后生物标志物

Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-03-27

多因素分析显示高TMTV(>20 cm3)和高SLR(>0.76)与更短5y-RFS相关,高SLR是低间质TILs的唯一独立相关因素。

要点

  • 基线高TMTV(>20 cm3)与高SLR(>0.76)与更短5年无复发生存独立相关。
  • 高SLR是低间质肿瘤浸润淋巴细胞(<50%)的唯一独立相关因素。
  • 脾代谢可能反映免疫抑制性肿瘤微环境。

核心结论

  • 基线[18F]-FDG PET/CT高总代谢肿瘤体积和高脾脏葡萄糖代谢与乳腺非特殊型癌术后更短5年无复发生存相关。
  • 脾代谢与间质肿瘤浸润淋巴细胞呈负相关,可能作为免疫抑制性肿瘤微环境的替代指标。

研究设计与样本

  • 从PET图像测量肿瘤SUVmax、总代谢肿瘤体积(TMTV)、脾与骨髓对肝脏SUVmax比值(SLR、BLR),用预测曲线确定预测5年无复发生存的截断值,用Cox回归建立多变量预测模型,用logistic回归分析其与间质肿瘤浸润淋巴细胞水平(<50%为低)的关联。

主要发现

  • 中位随访6.2年,56例复发、35例死亡,5年无复发生存率为86%。
  • 多因素分析中,高TMTV(>20 cm3)与更短5y-RFS相关(HR 2.4,95%CI 1.3-4.5),高SLR(>0.76)与更短5y-RFS相关(HR 1.9,95%CI 1.0-3.6)。
  • logistic回归中,高SLR是低间质TILs的唯一独立相关因素(OR 2.8,95%CI 1.4-5.7)。

关键数值与推荐

  • 高TMTV定义为>20 cm3,高SLR定义为>0.76,截断值由预测曲线确定以预测5年无复发生存。
  • 低间质肿瘤浸润淋巴细胞定义为<50%。

临床怎么用

  • 基线[18F]-FDG PET/CT测得的TMTV和SLR可用于乳腺非特殊型癌术后复发风险分层。
  • SLR升高提示间质TILs偏低,可能辅助识别免疫抑制性微环境。

局限性

  • 回顾性单中心设计。
  • 摘要未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated whether biomarkers on baseline [18F]-FDG PET/CT are associated with recurrence after surgery in patients with invasive breast cancer of no special type (NST). METHODS: In this retrospective single-center study, we included consecutive patients with non-metastatic breast cancer of NST who underwent [18F]-FDG PET/CT before treatment, including surgery, between 2011 and 2016. Clinicopathological data were collected. Tumor SUVmax, total metabolic tumor volume (TMTV), and spleen- and bone marrow-to-liver SUVmax ratios (SLR, BLR) were measured from the PET images. Cut-off values were determined using predictiveness curves to predict 5-year recurrence-free survival (5y-RFS). A multivariable prediction model was developed using Cox regression. The association with stromal tumor-infiltrating lymphocytes (TILs) levels (low if <50%) was studied by logistic regression. RESULTS: Three hundred and three women were eligible, including 93 (31%) with triple-negative breast carcinoma. After a median follow-up of 6.2 years, 56 and 35 patients experienced recurrence and death, respectively. The 5y-RFS rate was 86%. In multivariable analyses, high TMTV (>20 cm3) and high SLR (>0.76) were associated with shorter 5y-RFS (HR 2.4, 95%CI 1.3-4.5, and HR 1.9, 95%CI 1.0-3.6). In logistic regression, high SLR was the only independent factor associated with low stromal TILs (OR 2.8, 95%CI 1.4-5.7). CONCLUSION: High total metabolic tumor volume and high spleen glucose metabolism on baseline [18F]-FDG PET/CT were associated with poor 5y-RFS after surgical resection in patients with breast cancer of NST. Spleen metabolism was inversely correlated with stromal TILs and might be a surrogate for an immunosuppressive tumor microenvironment.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Seban RD, Rouzier R, Latouche A, et al. Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer. Eur J Nucl Med Mol Imaging. 2021. PMID: 33774685. doi:10.1007/s00259-021-05322-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。